Limon Jose J, Kershaw Kathleen M, Underhill David M
Department of Biomedical Sciences, and the F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute.
Department of Radiation Oncology, Cedars-Sinai Medical Center, Los Angeles, California, USA.
Curr Opin Gastroenterol. 2018 Nov;34(6):398-403. doi: 10.1097/MOG.0000000000000483.
The intestinal microbiota plays a central role in inflammatory diseases of the gut. Although most investigations regarding how the mucosal immune system interacts with the microbiota have focused on bacteria, recent studies are elucidating the additional role of commensal fungi in health and disease in the gut.
New technical approaches are defining the makeup of the fungal communities in the intestines of humans and mice. The reported composition of these communities is influenced by the approaches used to define the fungi. Changes in the intestinal mycobiota are associated with gut inflammation in patients with inflammatory bowel disease and in mouse models of colitis. Recent studies are beginning to elucidate the mechanisms by which the mucosal immune system interacts with and is influenced by intestinal fungi.
Studies clearly demonstrate the presence of intestinal fungi and document the ability of the mucosal immune system to recognize and respond to fungi. Future studies will further investigate whether intestinal fungi directly influence intestinal disease and what cellular, molecular, and genetic mechanisms contribute.
肠道微生物群在肠道炎症性疾病中起核心作用。尽管大多数关于黏膜免疫系统与微生物群如何相互作用的研究都集中在细菌上,但最近的研究正在阐明共生真菌在肠道健康和疾病中的额外作用。
新的技术方法正在确定人类和小鼠肠道中真菌群落的组成。这些群落的报告组成受用于定义真菌的方法影响。肠道真菌群的变化与炎症性肠病患者和结肠炎小鼠模型中的肠道炎症有关。最近的研究开始阐明黏膜免疫系统与肠道真菌相互作用并受其影响的机制。
研究清楚地证明了肠道真菌的存在,并记录了黏膜免疫系统识别和应对真菌的能力。未来的研究将进一步调查肠道真菌是否直接影响肠道疾病,以及哪些细胞、分子和遗传机制起作用。